Prostate and bone stromal cells substantially increased GDNF expression and secretion following genotoxic damage, indicating that GDNF produced in the tumor microenvironment could exert effects toward prostate cancer cells at the primary site and at the predominant site of metastasis. This evidence concerns the gene GDNF and prostate cancer.